Mayzent and Pneumococcal polysaccharides vaccine (PPSV), 23-valent

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer information for this interaction is not currently available.ADJUST DOSING INTERVAL: The administration of inactivated, killed, or otherwise noninfectious vaccines during siponimod therapy is generally safe but may be associated with a diminished or suboptimal immunologic response. Vaccination may be less effective during and for up to one month after discontinuation of siponimod therapy. MANAGEMENT: Immune response to vaccines may be reduced during and for up to one month after discontinuation of siponimod therapy. Treatment with siponimod should be paused 1 week prior to and for 4 weeks after vaccination. References "Product Information. Mayzent (siponimod)." Novartis Pharmaceuticals, East Hanover, NJ.

ADJUST DOSING INTERVAL: The administration of inactivated, killed, or otherwise noninfectious vaccines during siponimod therapy is generally safe but may be associated with a diminished or suboptimal immunologic response. Vaccination may be less effective during and for up to one month after discontinuation of siponimod therapy.

MANAGEMENT: Immune response to vaccines may be reduced during and for up to one month after discontinuation of siponimod therapy. Treatment with siponimod should be paused 1 week prior to and for 4 weeks after vaccination.

Mayzent

Generic Name: siponimod

Brand name: Mayzent, Mayzent Starter Pack

Synonyms: n.a.

What is Mayzent?

Pneumococcal polysaccharides vaccine (PPSV), 23-valent

Generic Name: pneumococcal 23-polyvalent vaccine

Brand name: Pneumovax 23

Synonyms: Pneumococcal Polysaccharide Vaccine (23-Valent)

What is Pneumococcal polysaccharides vaccine (PPSV), 23-valent?